CMHC West

May 4-5, 2018

Wynn Las Vegas

Advancing Cardiometabolic Health from East to West


Satellite Symposium Accreditation


CME Breakfast Symposium · Saturday, May 5, 2018 · 12:50 – 2:05pm

Updates in Inflammation and Secondary CVD Prevention


Target Audience

CMHC West is designed for US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.

Program Overview

Healthcare professionals agree on aggressive therapy for secondary prevention of CVD with statins, the cornerstone of therapy; however, recent focus has been given to the role of inflammation in the initiation and progression of atherosclerosis, the main cause of CVD, and as a treatment target for patients at risk. Observational evidence and results from clinical trials with statins have demonstrated that a reduction in inflammatory biomarkers, e.g., C-reactive protein (CRP), is associated with a reduction in cardiovascular events. A recent clinical trial has affirmed the hypothesis that reducing vascular inflammation in the absence of concomitant lipid lowering reduces the rates of cardiovascular events and demonstrated a 15% reduction in cardiovascular events compared to placebo.

During this symposium, Brendan M. Everett, MD and Ishwarlal Jialal, MD, PhD will provide an overview of the role of inflammation in the pathogenesis of atherosclerosis and atherothrombotic events and residual inflammatory risks in patients with CVD. The expert faculty will focus on the role of biomarkers in assessing secondary CVD risk and review the most recent clinical trial data from the completed CANTOS study and the ongoing CIRT trial. The session will conclude with an interactive patient case moderated by Christie M. Ballantyne, MD to demonstrate a patient at risk for secondary CVD and how managing inflammation may potentially reduce that risk. Participants will also be given the opportunity to pose questions and interact with the expert faculty during this time to enhance their knowledge and clinical practice.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Explain the role of inflammation in the underlying pathogenesis of the development and progression of atherosclerosis
  • Identify the role of inflammatory biomarkers in the assessment of secondary CVD risk
  • Review the results from clinical trials for emerging non-statin therapies targeting inflammation for the secondary prevention of CVD

Faculty

Christie M. Ballantyne, MD
Christie M. Ballantyne, MD (Chair)
  • Professor of Medicine
  • Chief, Section of Cardiovascular Research
  • Chief, Section of Cardiology
  • Department of Medicine, Baylor College of Medicine
  • Director, Center for Cardiovascular Disease Prevention
  • Baylor College of Medicine
  • Methodist DeBakey Heart Center
  • Houston, TX

Brendan M. Everett, MD
Brendan M. Everett, MD
  • Assistant Professor, HMS
  • Director, Impatient General Cardiology
  • Brigham and Women’s Hospital
  • Boston, MA

Ishwarlal Jialal, MD, PhD
Ishwarlal Jialal, MD, PhD
  • Assistant Dean of Research
  • Professor of Physiology, Metabolism and Pathology
  • California Northstate University - College of Medicine
  • Elk Grove, CA

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
There are 0.3 pharmacotherapy hours available for this activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Numbers (UAN): 0530-9999-18-115-L01-P

Dietician Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.25 Continuing Professional Education units (CPEUs) for completion of this activities / materials. CPE Provider #GE012

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the CMHC Program Evaluation provided at the time of this activity. An evaluation will be available to complete after the symposium via iPads that will be provided to all attendees. Upon completion of the evaluation, participants will be emailed their CME/CE Certificates within 5-7 business days.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed before July 3, 2018.

Fee Information & Refund/Cancellation Policy

There is registration fee for this educational activity, registration information can be found here.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager

Reported Financial Relationship

Ashley Marostica, RN, MSN

Nothing to disclose

Lindsay Borvansky

Nothing to disclose

Andrea Funk

Nothing to disclose

Amanda Turner

Nothing to disclose

Erin Franceschini, MS

Nothing to disclose

Amanda Jamrogiewicz

Nothing to disclose

Karin McAdams

Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Educational Grant Support

This satellite symposium is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Joint Providership Statement

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.


To view the full CMHC West satellite symposia schedule, please visit this page.

To view the full CMHC West agenda, please visit this page